STEM-engineered CAR T cells performed as well as or better against cancer cells than did FDA-approved CAR T cells and kept their cancer-fighting abilities for longer.

Their data suggests that tweaking the expression of FDX2 could make up for the loss of frataxin, the protein tied to FA's development.

By manipulating this pathway, scientists may be able to tweak the immune response to treat cancers, autoimmune disorders, and more.

A new brain-computer interface promises ultra-high resolution neural recording and wireless operation in a very small form.

In future, a more detailed understanding of the lung microbiome in pneumonia may enable improved diagnostics, prognosis, and therapeutics.

AIphafold helps make the first major inroad to date towards a new and more effective way to fight the monkeypox virus.

Scientists from the Netherlands used single compounds to speed up Raman spectroscopy for bioreactor analytics.

New ontologies for process data will help biopharmaceutical manufacturers enhance the interoperability of drug production operations ...

Maintaining MSC identity during expansion—another factor affected by media choice—enhances consistency among production lots and, therefore, is important in the regulatory pathway. As they point out, ...

Automated TCR-T production streamlines personalized immunotherapy, reducing patient burden and improving engineered T cell quality.

The agreement combines Cytiva’s Biacore surface plasmon resonance systems with Fidabio’s flow-induced dispersion analysis technology.

Cosmo Pharmaceuticals attracted welcome attention from investors and other market watchers after coming out with topline ...